跳至主要内容
临床试验/NCT05409144
NCT05409144Unknown不适用

Impact of Thoracic Epidural Infusion Versus Continuous Serratus Anterior Plane Block Versus Continuous Erector Spinae Plane Block on Incidence of Post Thoracotomy Pain Syndrome: A Randomized Controlled Trial

National Cancer Institute, Egypt0 个研究点目标入组 111 人开始时间: 2022年6月20日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
111
主要终点
Incidence of patients developing post-thoracotomy pain syndrome

研究概览

简要总结

The aim of this study is to evaluate the impact of Ultrasound-guided Erector Spinae plane block compared to Ultrasound-guided serratus anterior plane block on the emergence of post-thoracotomy pain syndrome in patients undergoing lobectomy for lung cancer.

详细描述

Lung cancer has the highest incidence of all malignancies worldwide and accounts for approximately 13% of all cancer cases. Lung cancer is still the most common cause of cancer-related deaths, and lung resection surgeries could be the main therapeutic option. Hence, the number of thoracotomy procedures is progressively increasing as is the incidence of post-thoracotomy pain. In addition to amputation and mastectomy, thoracotomy is considered the main etiology of severe and long-term acute and chronic post-surgical pain syndromes (CPSPs). The prevalence of post-thoracotomy pain syndrome (PTPS) is widely variable (30%-50%) and may range from 11% to 80%, according to other studies.

The International Association for the Study of Pain (IASP) has defined post-thoracotomy pain syndrome as "pain that recurs or persists along the thoracotomy scar at least 2 months after the procedure". In addition, post-thoracotomy pain syndrome is mostly described with neuropathic manifestations along the thoracotomy scar and in the mammary, inframammary, ipsilateral scapular and interscapular areas.

The ultrasound-guided erector spinae plane (ESP) block is a novel technique for thoracic analgesia that promises to be a relatively simple and safe alternative to more complex and invasive techniques of neural blockade.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age (18-65) Years
  • Physical status American Society of Anesthesiologists Classification II, III
  • Patients undergoing lobectomy through lateral thoracotomy
  • Body mass index (BMI): (20-40) kg/m2

排除标准

  • Patient refusal.
  • Age <18 years or >65 years
  • Body mass index (BMI) <20 kg/m2 and >40 kg/m2
  • Known sensitivity or contraindication to drugs used in the study
  • Contraindication to regional anesthesia e.g. local infection at site of introduction, pre-existing peripheral neuropathies and coagulopathy.
  • Pregnancy.
  • Physical status American Society of Anesthesiologists Classification IV
  • patients on chronic analgesic therapy (daily morphine ≥30 mg or equivalent dose of other opioids or tramadol or any medication for neuropathic pain)
  • patients with a history of drug abuse
  • patients with neuropsychiatric diseases; patients with a history of chronic pain syndromes that may enhance sensitivity to pain, for example, fibromyalgia
  • patients with a history of thoracic surgery through lateral thoracotomy; and patients with recurrent chest malignancies within 3 months.
  • All patients who developed severe intra- or post-operative bleeding or required postoperative mechanical ventilation were also excluded from the study.
  • Thoracic spine disorders or deformity.

结局指标

主要结局

Incidence of patients developing post-thoracotomy pain syndrome

时间窗: 12 weeks postoperatively

The incidence of patients developing post-thoracotomy pain syndrome according to grading system for neuropathic pain (GSNP

次要结局

  • Morphine consumption(48 hours Postoperatively)
  • Fentanyl consumption(Intraoperatively)
  • Post-thoracotomy pain syndrome severity(12 weeks postoperatively)
  • Patient's Quality of life(12 weeks postoperatively)
  • Postoperative Patient's activity level(12 weeks postoperatively)
  • Heart rate(Intraoperatively)
  • Mean arterial blood pressure(Intraoperatively)
  • Nausea and vomiting(24 hours postopertivley)
  • Post-operative pain(24 hours postopratively)
  • Time taken till 1st rescue analgesic request(24 hours postopratively)
  • Postoperative pulmonary complications(24 hours postopratively)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Shaban Mohammed

assisstant lecturer

National Cancer Institute, Egypt

相似试验